Enovix (ENVX) Capital Expenditures (2020 - 2026)

Enovix has reported Capital Expenditures for 7 years, with the latest figure at $9.3 million in Q2 2026.

• For the quarter ending Q2 2026, Capital Expenditures fell 20.52% year-over-year to $9.3 million; the trailing twelve-month figure through Apr 2026 stood at $7.8 million (down 89.24% YoY), and the FY2025 full-year result was $10.2 million, down 86.63% from the prior year.
• Capital Expenditures for Q2 2026 stood at $9.3 million, up from -$7.0 million in the prior quarter.
• The five-year high for Capital Expenditures was $61.7 million in Q4 2024, with the low at -$25.8 million in Q3 2024.
• Historically, Capital Expenditures has averaged $9.8 million across 5 years, with a median of $10.1 million in 2025.
• The largest YoY upside for Capital Expenditures was 463.02% in 2024 against a maximum downside of 250.03% in 2024.
• Enovix's Capital Expenditures stood at $1.5 million in 2022, then tumbled by 1225.76% to -$17.0 million in 2023, then soared by 463.02% to $61.7 million in 2024, then plunged by 111.39% to -$7.0 million in 2025, then soared by 232.17% to $9.3 million in 2026.
• The last three Capital Expenditures figures came in at $9.3 million (Q2 2026), -$7.0 million (Q4 2025), and $10.1 million (Q3 2025), per Business Quant data.